Apellis Pharmaceuticals (APLS) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to 1.08.
- Apellis Pharmaceuticals' Asset Utilization Ratio rose 3653.47% to 1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.08, marking a year-over-year increase of 3653.47%. This contributed to the annual value of 0.93 for FY2024, which is 8232.66% up from last year.
- Latest data reveals that Apellis Pharmaceuticals reported Asset Utilization Ratio of 1.08 as of Q3 2025, which was up 3653.47% from 0.93 recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Asset Utilization Ratio ranged from a high of 1.08 in Q3 2025 and a low of 0.08 during Q1 2022
- In the last 5 years, Apellis Pharmaceuticals' Asset Utilization Ratio had a median value of 0.33 in 2021 and averaged 0.45.
- As far as peak fluctuations go, Apellis Pharmaceuticals' Asset Utilization Ratio plummeted by 7296.57% in 2022, and later surged by 43439.05% in 2023.
- Over the past 5 years, Apellis Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.09 in 2021, then fell by 2.35% to 0.09 in 2022, then soared by 434.39% to 0.49 in 2023, then soared by 77.18% to 0.87 in 2024, then grew by 23.63% to 1.08 in 2025.
- Its last three reported values are 1.08 in Q3 2025, 0.93 for Q2 2025, and 0.92 during Q1 2025.